 |
|
Recommendations for the Use of Lyme Disease Vaccine
Arch Dermatol. 1999;135:1425-1426.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
LYME DISEASE vaccine does not protect all recipients against infection with B. burgdorferi and offers no protection against other tickborne diseases. Vaccinated persons should continue to practice personal protective measures against ticks and should seek early diagnosis and treatment of suspected tickborne infections. Because Lyme disease is not transmitted person-to-person, use of the vaccine will not reduce risk among unvaccinated persons. Decisions regarding the use of vaccine should be based on individual assessment of the risk for exposure to infected ticks and on careful consideration of the relative risks and benefits of vaccination compared with other protective measures, including early diagnosis and treatment of Lyme disease. The risk for Lyme disease is focally distributed in the United States. Detailed information regarding the distribution of Lyme disease risk within specific areas is best obtained from state and local public health authorities.
The following recommendations are made regarding use of Lyme disease . . . [Full Text of this Article] Persons Who Reside, Work, or Recreate in Areas of High or Moderate Risk
Persons Who Reside, Work, or Recreate in Areas of Low or No Risk
Travelers to Areas of High or Moderate Risk
Children Aged <15 Years
Persons Aged >70 Years
Pregnant Women
Persons With Immunodeficiency
Persons With Musculoskeletal Disease
Persons With a Previous History of Lyme Disease
Vaccine Schedule, Including Spacing and Timing of Administration
Boosters
Simultaneous Administration With Other Vaccines
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
